GPX4 and hepatocellular carcinoma: Moreover, the inhibition of GPX4 expression by RSL-3 treatment robustly restored lipid ROS levels, and the percentage of PI-positive cells, which were suppressed by NeuroD1 overexpression in HCC-LM3 cells (S8A and S8B Fig).